eif4g1 (Proteintech)
Proteintech is a verified supplier 
95
Structured Review
Proteintech
eif4g1
Eif4g1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 56 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4g1/EIF4G1+Antibody/pmc13049607-338-47-48
Average 95 stars, based on 56 article reviews
Eif4g1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 56 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eif4g1/EIF4G1+Antibody/pmc13049607-338-47-48
Average 95 stars, based on 56 article reviews
eif4g1 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Saline:Article Title: Translation factor eIF4G2 directs CD8 + T cell lineage commitment by selectively enabling the IL-7 receptor response Article Snippet: Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore). .. Membranes were blocked with 5% non-fat milk or bovine serum albumin (BSA) in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 1 hour at room temperature and then incubated overnight at 4 °C with the following primary antibodies diluted in blocking buffer: eIF4G2 (CST, 3468S), β-actin (CST, 3700S), Incubation:Article Title: Translation factor eIF4G2 directs CD8 + T cell lineage commitment by selectively enabling the IL-7 receptor response Article Snippet: Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore). .. Membranes were blocked with 5% non-fat milk or bovine serum albumin (BSA) in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 1 hour at room temperature and then incubated overnight at 4 °C with the following primary antibodies diluted in blocking buffer: eIF4G2 (CST, 3468S), β-actin (CST, 3700S), Article Title: Vimentin Regulates Alternative Polyadenylation and mTOR Signaling via ARVCF to Promote B Cell Lymphoma Progression Article Snippet: .. Membranes were blocked with 5% nonfat milk for 2 h and incubated overnight at 4°C with the following primary antibodies: mTOR (66888-1-Ig, Proteintech, 1:1000); Phospho-mTOR (Ser2448) (67778-1-Ig, Proteintech, 1:1000); Blocking Assay:Article Title: Translation factor eIF4G2 directs CD8 + T cell lineage commitment by selectively enabling the IL-7 receptor response Article Snippet: Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore). .. Membranes were blocked with 5% non-fat milk or bovine serum albumin (BSA) in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 1 hour at room temperature and then incubated overnight at 4 °C with the following primary antibodies diluted in blocking buffer: eIF4G2 (CST, 3468S), β-actin (CST, 3700S), other:Article Title: E0703 targets ERβ to facilitate the upregulation of GLI3, thereby alleviating irradiation-induced DNA damage on lymphocytes Article Snippet: Protein–protein interactions were identified using the Pierce Crosslink Immunoprecipitation Kit (no. 26147, Thermo Fisher Scientific). Article Title: E0703 targets ERβ to facilitate the upregulation of GLI3, thereby alleviating irradiation-induced DNA damage on lymphocytes Article Snippet: Protein concentration was assessed with the BCA Protein Assay Kit (Beyotime, P0010S), and proteins were separated by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and then transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, IPVH00010). Article Title: E0703 targets ERβ to facilitate the upregulation of GLI3, thereby alleviating irradiation-induced DNA damage on lymphocytes. Article Snippet: Cells were harvested at 6 h post IR (5 Gy) and lysed with M-PER Mammalian Protein Extraction Reagent (no. 78501, Thermo Fisher) supplemented with protease and phosphatase inhibitors. Western Blot:Article Title: Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82070219 and 81870157; Faculty Start Fund; Sichuan Natural Science Foundation, Grant/Award Number: 24NSFSC3229; 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University, Grant/Award Number: ZYJC21007; Key Research and Development Program of Sichuan Province, Grant/ Award Number: 2023YFS0031; National Key Research and Development Program of China, Grant/Award Number: 2022YFC2502600 and 2022YFC2502603; National Natural Science Foundation of China, Grant/Award Number: 82370192 Summary Multiple myeloma (MM) is an incurable plasma cell cancer in the bone marrow.. Immunomodulatory drugs, such as lenalidomide (LEN) and pomalidomide, are backbone agents in MM treatment, and LEN resistance is commonly seen in the MM clinic.. In this study, we presented that heterogeneous nuclear ribonucleoprotein U (hnRNPU) affected MM resistance to LEN via the regulation of target mRNA translation. hnRNPULow MM cells exhibited upregulated CRBN and IKZF1 proteins, stringent IKZF1/3 protein degradation upon LEN addition and increased sensitivity to LEN. |